Search Results - "Buas, Matthew F."

Epidemiology and Risk Factors for Gastroesophageal Junction Tumors: Understanding the Rising Incidence of This Disease by Buas, Matthew F., PhD, Vaughan, Thomas L., MD, MPH

“…Gastroesophageal (GE) junction carcinoma is a rare but often lethal condition with increasing importance as a public health problem in recent decades. Whereas…”
Get full text

Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls by Lohavanichbutr, Pawadee, Zhang, Yuzheng, Wang, Pei, Gu, Haiwei, Nagana Gowda, G A, Djukovic, Danijel, Buas, Matthew F, Raftery, Daniel, Chen, Chu

“…Oral cavity squamous cell carcinoma (OCC) and oropharyngeal squamous cell carcinoma (OPC) are among the most common cancers worldwide and are associated with…”
Get full text

Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors by Buas, Matthew F, Gu, Haiwei, Djukovic, Danijel, Zhu, Jiangjiang, Drescher, Charles W, Urban, Nicole, Raftery, Daniel, Li, Christopher I

“…Abstract Objective Serous ovarian carcinoma (OC) represents a leading cause of cancer-related death among U.S. women. Non-invasive tools have recently emerged…”
Get full text

The Notch Effector Hey1 Associates with Myogenic Target Genes to Repress Myogenesis by Buas, Matthew F., Kabak, Shara, Kadesch, Tom

“…Members of the Hey family of transcriptional repressors are basic helix-loop-helix proteins that are thought to act downstream of Notch in diverse tissues…”
Get full text

Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass by Buas, Matthew F., Drescher, Charles W., Urban, Nicole, Li, Christopher I., Bettcher, Lisa, Hait, Nitai C., Moysich, Kirsten B., Odunsi, Kunle, Raftery, Daniel, Yan, Li

“…Altered lipid metabolism has emerged as an important feature of ovarian cancer (OC), yet the translational potential of lipid metabolites to aid in diagnosis…”
Get full text

Inhibition of myogenesis by Notch: Evidence for multiple pathways by Buas, Matthew F., Kabak, Shara, Kadesch, Tom

“…Notch signaling is critical for skeletal muscle development and regeneration, permitting the expansion of progenitor cells by preventing premature…”
Get full text

SNP Regulation of microRNA Expression and Subsequent Colon Cancer Risk by Mullany, Lila E, Wolff, Roger K, Herrick, Jennifer S, Buas, Matthew F, Slattery, Martha L

“…MicroRNAs (miRNAs) regulate messenger RNAs (mRNAs) and as such have been implicated in a variety of diseases, including cancer. MiRNAs regulate mRNAs through…”
Get full text

Genes Relevant to Tissue Response to Cancer Therapy Display Diurnal Variation in mRNA Expression in Human Oral Mucosa by Gu, Fangyi, Gomez, Eduardo Cortes, Chen, Jianhong, Buas, Matthew F, Schlecht, Nicolas F, Hulme, Karen, Kulkarni, Shweta Vishwas, Singh, Prashant K, O'Connor, Richard, Ambrosone, Christine B, Singh, Anurag K, Wang, Jianmin

“…To address a critical gap for application of cancer chronotherapy of when would be the best time(s) for treating an individual cancer patient, we conducted a…”
Get full text

Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett’s Esophagus by Dai, James Y., Tapsoba, Jean de Dieu, Buas, Matthew F., Chow, Wong-Ho, Shaheen, Nicholas J., Anderson, Lesley, Corley, Douglas A., Gammon, Marilie D., Hardie, Laura J., Lagergren, Jesper, Whiteman, David C., Risch, Harvey A., Vaughan, Thomas L.

“…Few gene-environment interactions (G × E) have been discovered in cancer epidemiology thus far, in part due to the large number of possible G × E to be…”
Get full text

Regulation of skeletal myogenesis by Notch by Buas, Matthew F., Kadesch, Tom

“…Notch signaling has emerged as a key player in skeletal muscle development and regeneration. Simply stated, Notch signaling inhibits differentiation…”
Get full text

Survival disparities among racial/ethnic groups of women with ovarian cancer: An update on data from the Surveillance, Epidemiology and End Results (SEER) registry by Stenzel, Ashley E., Buas, Matthew F., Moysich, Kirsten B.

“…•Non-Hispanic black women have worse survival compared to non-Hispanic white women.•This survival difference is more pronounced among women diagnosed under age…”
Get full text

A risk variant for Barrett's esophagus and esophageal adenocarcinoma at chr8p23.1 affects enhancer activity and implicates multiple gene targets by Ali, Mourad Wagdy, Chen, Jianhong, Yan, Li, Wang, Xiaoyu, Dai, James Y, Vaughan, Thomas L, Casey, Graham, Buas, Matthew F

“…Nineteen genetic susceptibility loci for esophageal adenocarcinoma (EAC) and its precursor Barrett's esophagus (BE) have been identified through genome-wide…”
Get full text

Prioritization and functional analysis of GWAS risk loci for Barrett’s esophagus and esophageal adenocarcinoma by Chen, Jianhong, Ali, Mourad Wagdy, Yan, Li, Dighe, Shruti G, Dai, James Y, Vaughan, Thomas L, Casey, Graham, Buas, Matthew F

“…Abstract Genome-wide association studies (GWAS) have identified ~20 genetic susceptibility loci for esophageal adenocarcinoma (EAC), and its precursor,…”
Get full text

Differences in microRNA expression in breast cancer between women of African and European ancestry by Gong, Zhihong, Wang, Jie, Wang, Dan, Buas, Matthew F, Ren, Xuefeng, Freudenheim, Jo L, Belinsky, Steven A, Liu, Song, Ambrosone, Christine B, Higgins, Michael J

“…A number of miRNAs were differentially expressed by tumor subtype and between races. These ER-subtype and race-related miRNAs may represent promising candidate…”
Get full text

Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study by Buas, Matthew F., Rho, Jung-hyun, Chai, Xiaoyu, Zhang, Yuzheng, Lampe, Paul D., Li, Christopher I.

“…Estrogen receptor (ER)-positive/progesterone receptor (PR)-positive invasive ductal carcinoma accounts for ~45 % of invasive breast cancer (BC) diagnoses in…”
Get full text

FOXA1 Protein Expression in ER + and ER - Breast Cancer in Relation to Parity and Breastfeeding in Black and White Women by Cheng, Ting-Yuan David, Yao, Song, Omilian, Angela R, Khoury, Thaer, Buas, Matthew F, Payne-Ondracek, Rochelle, Sribenja, Sirinapa, Bshara, Wiam, Hong, Chi-Chen, Bandera, Elisa V, Davis, Warren, Higgins, Michael J, Ambrosone, Christine B

“…Forkhead box protein A1 (FOXA1) promotes luminal differentiation, and hypermethylation of the gene can be a mechanism of developing estrogen receptor-negative…”
Get full text

Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett’s esophagus, and high-grade dysplasia/esophageal adenocarcinoma by Buas, Matthew F., Gu, Haiwei, Djukovic, Danijel, Zhu, Jiangjiang, Onstad, Lynn, Reid, Brian J., Raftery, Daniel, Vaughan, Thomas L.

“…Introduction/objectives Incidence of esophageal adenocarcinoma (EA), an often fatal cancer, has increased sharply over recent decades. Several important risk…”
Get full text

FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women? by Espinal, Allyson C., Buas, Matthew F., Wang, Dan, Cheng, David Ting-Yuan, Sucheston-Campbell, Lara, Hu, Qiang, Yan, Li, Payne-Ondracek, Rochelle, Cortes, Eduardo, Tang, Li, Gong, Zhihong, Zirpoli, Gary, Khoury, Thaer, Yao, Song, Omilian, Angela, Demissie, Kitaw, Bandera, Elisa V., Liu, Song, Ambrosone, Christine B., Higgins, Michael J.

“…Background Reproductive factors, particularly parity, have differential effects on breast cancer risk according to estrogen receptor (ER) status, especially…”
Get full text

Targeted plasma metabolome response to variations in dietary glycemic load in a randomized, controlled, crossover feeding trial in healthy adults by Barton, Sally, Navarro, Sandi L, Buas, Matthew F, Schwarz, Yvonne, Gu, Haiwei, Djukovic, Danijel, Raftery, Daniel, Kratz, Mario, Neuhouser, Marian L, Lampe, Johanna W

“…Low versus high glycemic load (GL) diet patterns are inversely associated with obesity and chronic diseases such as cancer and cardiovascular disease. These…”
Get more information

Recommendation to use exact P-values in biomarker discovery research in place of approximate P-values by Buas, Matthew F., Li, Christopher I., Anderson, Garnet L., Pepe, Margaret S.

“…•Normal and logit-normal approximate P-values are frequently used in biomarker studies.•Approximate P-values can lead to inappropriate biomarker selection…”
Get full text